What are the pancreatic target cells for gastrin and its CCKB receptor? Is this a couple for cancerous cells?

Medical Science Monitor

Volumn 10, Issue 10, 2004, Pages

  Morisset, Jean ^a   Lainé, Jean ^a   Biernat, Marzena ^a   Julien, Sophie ^a  

^a UNIVERSITY OF SHERBROOKE   (Canada)

Author keywords

CCK receptor subtypes; Pancreas; Pancreas growth; Pancreatic cancer; Pancreatic secretion

Indexed keywords

CHOLECYSTOKININ A RECEPTOR; CHOLECYSTOKININ B RECEPTOR; CHOLECYSTOKININ RECEPTOR BLOCKING AGENT; GASTRIN; PANCREAS ENZYME; RECEPTOR SUBTYPE;

ACINAR CELL; ACUTE PANCREATITIS; ANIMAL CELL; AUTOCRINE EFFECT; CANCER CELL; CANCER GROWTH; ENZYME RELEASE; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; MAMMAL; METAPLASIA; NONHUMAN; PANCREAS CANCER; PANCREAS CELL; PANCREAS ISLET ALPHA CELL; PANCREAS ISLET BETA CELL; RAT; REGENERATION; REVIEW; SWINE; TARGET CELL;

ANIMALS; GASTRINS; HUMANS; PANCREAS; PANCREATIC NEOPLASMS; RECEPTOR, CHOLECYSTOKININ A; RECEPTOR, CHOLECYSTOKININ B; REGENERATION;

EID: 7044254646     PISSN: 12341010     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (50)

1. Sankaran H, Goldfine ID, Deveney CW et al: Binding of cholecystokinin to high affinity receptors on isolated rat pancreatic acini. J Biol Chem, 1980; 255: 1849-53
2. Presti ME, Gardner JD; Receptor antagonists for gastrointestinal peptides. Am J Physiol, 1993; 264: G399-406
3. Wank SA, Harkins R, Jensen RT et al: Purification, molecular cloning and functioning expression of the cholecystokinin receptor from rat pancreas. Proc Natl Acad Sci USA, 1992; 89: 3125-29
4. Lee YM, Beinborn M, McBride EW et al: The human brain cholecystokinin-B/gastrin receptor: Cloning and characterization. J Biol Chem, 1993; 268: 8164-69
5. Chang RSL, Lotti VJ, Keegan ME, Kunkel KA: Characterization of [3H]-pentagasirin binding in guinea pig glands. Biochem Biophys Res Commun, 1986; 134: 895-99
6. Saito A, Sankaran H, Goldfine ID, Williams JA: Characterization of receptors for cholecystokinin and related peptides in mouse cerebral cortex. J Neurochem, 1981; 37: 483-90
7. Lotti VJ, Chang RSL: A potent and selective nonpeptide gastrin antagonist and brain (CCKB) receptor ligand: L-365,260. Eur J Pharmacol, 1989; 163: 273-80
8. Chang RSL, Lotti VJ: Biochemical and pharmacologic characterisation of a new extremely potent and selective nonpeptide cholecystokinin antagonist. Proc Natl Acad Sci USA, 1986; 83: 4923-26
9. Cuber JC, Corring T, Levenez F et al: Effects of cholecysiokinin octapeptide on the pancreatic exocrine secretion in the pig. Can J Physiol Pharmacol, 1989; 67: 1391-97
10. Morisset J, Levenez F, Coning T et al: Pig pancreatic acinar cells possess predominantly the CCK-B receptor subtype. Am J Physiol, 1996; 271: E397-402
11. Cantor P, Petronijevic L, Pedersen JF, Warning H: Cholecystokinetic and pancreozymic effect of O-sulfated gastrin compared with nonsulfated gastrin and cholecystokinin. Gastroenterologe, 1986; 91: 1154-63
12. Cantor P, Mortensen PE, Myhre J et al: The effect of the cholecystokinin receptor antagonist MK-329 on meal-stimulated pancreatico-biliary output in humans. Gastroenterology, 1992; 102: 1742-51
13. Susini C, Estival A, Scemama JL et al: Studies on human pancreatic acini: action of secretagogues on amylase release and cellular cyclic AMP accumulation. Pancreas, 1986; 1: 124-29
14. Ji B, Bi Y, Simeone D et al: Human pancreatic acinar cells lack functional responses to cholecystokinin and gastrin. Gastroenterology, 2001; 121: 1380-90
15. Saillan-Barreau C, Clerc P, Adato M et al: Transgenic CCK-B/gastrin receptor mediates murine exocrine pancreatic secretion. Gastroenterology, 1998; 115: 988-96
16. Morisset J, Wong H, Walsh JH et al: Pancreatic CCKB receptors: their potential roles in somatostatin release and d-cell proliferation. Am J Physiol, 2000; 279: G148-56
17. Kouturek SJ, Zabielski R, Konturek JVV, Czarnecki J: Neuroendocrinology of the pancreas: role of brain-gut axis in pancreatic secretion. Eur J Pharmacol, 2003; 481: 1-14
18. Brants F, Morisset J: Trophic effect of cholecystokinin-pancreozymin on pancreatic acinar cells from rats of different ages. Proc Soc Exptl Biol Med, 1976; 153: 523-27
19. Morisset J, Lainé J, Mimeau-Worthington T: Hormonal control of rat foetal pancreas development. Biol of the Neonate, 1999; 75: 327-30
20. Morisset J, Grondin G: Dynamics of pancreatic tissue cells in the rat exposed to long-term caerulein treatment. 2 comparative analysis of the various cell types and their growth. Biol of the Cell, 1989; 66: 279-90
21. Rivard N, Guan D, Maouyo D et al: Endogenous cholecystokinin release responsible for pancreatic growth observed after pancreatic juice diversion. Endocrinology, 1991; 129: 2867-74
22. Green GM, Levan VH, Liddle RA: Plasma cholecystokinin and pancreatic growth during adaptation to dietary protein. Am J Physiol, 1986; 251: G70-74
23. Green GM, Jurkowska G, Bérubé FL et al: Role of cholecystokinin in induction and maintenance of dietary protein-stimulated pancreatic growth. Am J Physiol, 1992; 262: G740-46
24. Morissei J, Guan D, Jurkowska G et al: Endogenous cholecystokinin, the major factor responsible for dietary protein-induced pancreatic growth. Pancreas, 1992; 7: 522-29
25. Jurkowska G, Grondin G. Massé S, Morisset J: Soybean Trypsin inhibitor and cerulein accelerate recovery of cerulein-induced pancreatitis in rats. Gastroenterology. 1992; 102: 550-62
26. Jurkowska G, Grondin G, Morisset J: Involvement of endogenous cholecystokinin in pancreatic regeneration after cerulein-induced acute pancreatitis. Pancreas, 1992; 7: 295-304
27. Mayston PD, Barrowman JA: The influence of chronic administration of pentagastrin on the rat pancreas. QJ Exp Physiol, 1971; 56: 113-22
28. Majumdar APN, Golterman N: Chronic administration of pentagastrin. Effects on pancreatic protein and nucleic acid contents and protein synthesis in rats. Digestion, 1979; 19: 144-47
29. Solomon TE, Morisset J, Wood JG, Bussjaeger LJ: Additive interaction of pentagastrin and secretin on pancreatic growth in rats. Gastroenterology, 1987; 92: 429-35
30. Jensen RT, Lemp FG, Gardner JD: Interaction of cholecystokinin with specific membrane receptors on pancreatic acinar cells. Proc Natl Acad Sci USA, 1980; 77: 2079-83
31. Clerc P, Leung-Theung-Long S, Wang TC et al: Expression of CCK2 reeptors in the murine pancreas: proliferation, transindifferenciation of acinar cells and neoplasia. Gastroenterology, 2002; 122: 428-37
32. Tang C, Biemond I, Lamers CBHW: Cholecystokinin receptors in human pancreas and gallbladder muscle: a comparative study. Gastroenterology, 1996; 111: 1621-26
33. Friess H, Kleeff J, Isenmann R et al: Adaptation of the human pancreas to inhibition of luminal proteolylic activity. Gastroenterology, 1998; 115: 388-96
34. Tsiotos GG, Barry MK, Johnson CD, Sarr MG: Pancreas regeneration after resection: does it occur in human? Pancreas, 1999; 19: 310-13
35. Fiorucci S, Bufalari A, Distrutti F: Bombesin-induced pancreatic regeneration in pigs is mediated by p46shc/p52shc and p42/p44 mitogen-activated protein kinase upregulation. Scand J Gastroenterol, 1998; 33: 1310-20
36. Morisset J, Morisset S, Lanzon K et al: Paricreatic inflammation, apoptosis and growth: sequential events after partial pancreatectomy in pigs. Pancreas, 2000; 21: 321-25
37. Rooman I, Lardon J, Flamez D et al: Mitogenic effect of gasirin and expression of gasirin receptors induct-like cells of rat pancreas. Gastroenterology, 2001; 121: 940-49
38. Schweiger M, Erhard MH, Amselgruber WM: Cell-specific localization of the cholecystokininA receptor in the porcine pancreas. Anat Histol Embryol, 2000; 29: 357-61
39. Morisset J, Botrrassa J, Tessier P et al: The pancreatic CCKB receptor: the existing controversy about its cellular location among species. Pancreatology, 2002; 2: 276
40. Morisset J, Bourassa J, Tessier P et al: Presence and localization of CCK receptor subtypes in calf pancreas. Regul Peptides, 2003; 111: 103-9
41. Morisset J, Calvo E: Trophicity of the pancreas: from rodent to man. J Physiol Pharmacol, 1998; 49(Suppl.2): 25-37
42. Kloppel G, Maillet B: Classification and staging of pancreatic non endocrine tumors. Radiol Clin North Am, 1989; 27: 105-19
43. Ohlsson B, Fredang N, Axelson J: The effect of bombesin, cholecystokinin, gastrin, and their antagonists on proliferation of pancreatic cancer cell lines. Scand J Gastroenterol, 1999; 34: 1224-29
44. McWilliams DF. Watson SA, Crosbee DM et al: Coexpression of gastrin and gastrin receptors (CCK-B and ΔCCK-B) in gastrointestinal tumour cell lines. Gut, 1998; 42: 795-98
45. Palmer Smith J, Liu G, Soundararajan V et al: Identification and characterization of CCK-B/gastrin receptors in human pancreatic cancer cell lines. Am J Physiol, 1994; 266: R277-83
46. Douziech N, Lajas A, Coulombe Z et al: Growth effects of regulatory peptides and intracellular signaling routes in human pancreatic cancer cell lines. Endocrine, 1998; 9: 171-83
47. Goetze JP, Nielsen FC, Burcharth F, Rehfeld JF: Closing the gastrin loop in pancreatic carcinoma. Co-expression of gastrin and its receptor in solid human pancreatic adenocarcinoma. Cancer, 2000; 88: 2487-94
48. Weinberg DS, Ruggeri B, Barber MT et al: Cholecystokinin A and B receptors are differentially expressed in normal pancreas and pancreatic adenocarcinoma. J Clin Invest, 1997; 100: 597-603
49. Bourassa J, Laine J, Kruse ML et al: Ontogeny and species differences in the pancreatic expression and localization of the CCKA receptors. Biochem Biophys Res Commun, 1999; 260: 820-28
50. Caplin ME, Clarke P, Grimes S et al: Demonstration of new sites of expression of the CCK-B/gastrin receptor in pancreatic acinar AR42J cells using immunoelectron microscopy. Reg Peptides, 1999; 84: 81-89